Inventor

Stephen John Davies

Inventor
Abingdon, GB

Overview

23→
Patents
2002–2019
Patent span
Chemistry
Primary field (CPC C)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes17%
C07CAcyclic or carbocyclic compounds13%
C07KPeptides6%
A63BApparatus for physical training, gymnastics, swimming, climbing, or fencing1%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G05BControl or regulating systems in general1%
G06FElectric digital data processing1%
H05KPrinted circuits1%
PatentTitleYear
10,370,332Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-YL]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof20199,896,417'Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof'20189,636,409'Enzyme and receptor modulation using covalent conjugates of alpha,alpha-disubstituted glycine esters'20179,604,940'2-aminopyrazine derivatives as CSF-1R kinase inhibitors'20179,573,016'Exercise device for supporting weight from hand grips using straps'20179,388,136'Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof'20169,133,104'Enzyme inhibitors'20158,778,953'Inhibitors of P38 map kinase'20148,686,032'Enzyme inhibitors'20148,148,531'Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity'20128,106,091'Inhibitors of IKK-beta serine-threonine protein kinase'20128,044,211'P38 MAP kinase inhibitors'20118,003,695'IKK-beta serine-threonine protein kinase inhibitors'20117,939,666'Enzyme inhibitors'20117,786,121'Derivatives of hydroxamic acid as metalloproteinase inhibitors'20107,358,265'Oxa-and thiadiazoles and their use as metalloproteinase inhibitors'20087,323,448'Antibacterial agents'20087,148,198'Antibacterial agents'20066,908,911'Antibacterial agents'20056,898,540'System and method for displaying real-time turbine corrected output and heat rate'20056,787,522'Antibacterial agents'20046,423,690'Antibacterial agents'20026,396,688'Series fan speed control system'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2008Patents assigned to BRITISH BIOTECH PHARM (5)· patent assignee history
2004–2008Based in Cowley, GB· patent location history
2005Based in Clifton Park, NY, US· patent location history
2008Based in Oxfordshire, GB· patent location history
2010–2019Based in Abingdon, GB· patent location history
2011–2018Patents assigned to CHROMA THERAPEUTICS LTD (11)· patent assignee history
2012–2014Patents assigned to DAVIES STEPHEN JOHN (4)· patent assignee history
2012–2014Patents assigned to DAVIDSON ALAN HORNSBY (2)· patent assignee history
2017Based in Winnipeg, CA· patent location history
2018–2019Patents assigned to MACROPHAGE PHARMA LTD (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CHROMA THERAPEUTICS LTD112011–2018
BRITISH BIOTECH PHARM52002–2008
DAVIES STEPHEN JOHNself42012–2014
DAVIDSON ALAN HORNSBY22012–2014
MACROPHAGE PHARMA LTD22018–2019
Locations
LocationPatentsSpan
Abingdon, GB142010–2019
Cowley, GB42004–2008
Winnipeg, CA12017
Oxfordshire, GB12008
Clifton Park, New York, US12005